CollagenPro
As per the warning by the World Health Organization (WHO), antimicrobial resistance is giving way to gonorrhea. It seems quite difficult to treat the same at times. Health officials all across the globe are in a big fix and looking for a solution.
The disease called Gonorrhea is caused by the smart bacterium. Each time the doctors prefer to use a new set of antibiotics to combat this deadly infection, these bacteria show drug resistance. They tend to work against the disease and thus become difficult to counter them as conveyed by the World Health Organization (WHO) medical officer. In fact, the bacterium is leading to sexually transmitted infection (STI).
Effects of drug resistance
If one goes by the words of the experts the number of people getting affected by this so called sexually transmitted disease is on the rise. The total count around the world is approximately 78 million people. This disease can be seen extremely in the countries where people have low-income and cannot be treated for the same. The systems are lacking the required infrastructure and thus are incompatible to report the numbers accurately. In fact, the cases reported are just a small example relating to the disease.
The sexually transmitted infection is causing havoc to the bodies of the women by increasing the risk of pelvic inflammatory disease, ectopic pregnancy and the problem of infertility, even the increased risk of HIV. Among the men, it can affect the genitals, rectum, and throat. Thus gonorrhea spreads from the infected partner to the healthy one making both the partners susceptible to the disease.
Drugs showing resistance in human bodies
It is evident from the records that three particular antibiotics are proving unsuccessful when it comes to the drug resistance and antimicrobial resistance from the disease. Some of the figures go as below:
- 97% of the countries showed resistance to the antibiotic ciprofloxacin
- 81% of the countries showed resistance to the antibiotic azithromycin
- 66% of the countries started showing resistance to the last resort treatment.
The above-mentioned data is the result of the research collected from 77 countries during the period of 2009 to 2014. As per the World Health Organization (WHO) officials, there is an increased need to develop fresh drugs that can treat gonorrhea as soon as possible without any further delays in the process due to this reason.
Thus the new antibiotics are needed to beat this superbug called gonorrhea and fight back with all the power. The emergence of modern drugs will not be suitable for the commercial pharmaceutical companies. The present drugs and the already existing companies in the market need to capture this opportunity and make the same.
To conclude, it can be gathered from the above research that new treatment needs to be developed and must be within the reach of one and all. Drug resistance must be reduced to the maximum possible extent without a saying. In fact, it should only be used as per the need and not otherwise.